Bank of America’s Spyre Therapeutics SYRE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.93M | Sell |
|
|||||
|
2025
Q1 | $6.89M | Buy |
|
|||||
|
2024
Q4 | $166K | Sell |
|
|||||
|
2024
Q3 | $7.58M | Buy |
|
|||||
|
2024
Q2 | $4.49M | Buy |
|
|||||
|
2024
Q1 | $1.38M | Buy |
|
|||||
|
2023
Q2 | – | Sell |
|
|||||
|
2023
Q1 | $10.2K | Buy |
|
|||||
|
2022
Q4 | $7.08K | Buy |
|
|||||
|
2022
Q3 | $6K | Buy |
|
|||||
|
2022
Q2 | $4K | Sell |
|
|||||
|
2022
Q1 | $41K | Sell |
|
|||||
|
2021
Q4 | $147K | Buy |
|
|||||
|
2021
Q3 | $204K | Buy |
|
|||||
|
2021
Q2 | $141K | Sell |
|
|||||
|
2021
Q1 | $314K | Buy |
|
|||||
|
2020
Q4 | $106K | Sell |
|
|||||
|
2020
Q3 | $351K | Buy |
|
|||||
|
2020
Q2 | $179K | Buy |
|
|||||
|
2020
Q1 | $63K | Sell |
|
|||||
|
2019
Q4 | $191K | Sell |
|
|||||
|
2019
Q3 | $214K | Buy |
|
|||||
|
2019
Q2 | $182K | Buy |
|
|||||
|
2019
Q1 | $111K | Sell |
|
|||||
|
2018
Q4 | $128K | Buy |
|
|||||
|
2018
Q3 | $41K | Buy |
|
|||||
|
2018
Q2 | $31K | Sell |
|
|||||
|
2018
Q1 | $74K | Buy |
|
|||||
|
2017
Q4 | $38K | Hold |
|
|||||
|
2017
Q3 | $35K | Buy |
|
|||||
|
2016
Q4 | – | Sell |
|
|||||
|
2016
Q3 | $3K | Sell |
|
|||||
|
2016
Q2 | $4K | Buy |
|